Minuteful - kidney test

The Minuteful - kidney test is a prescription-based, home-use system enabling individuals at risk of kidney disease to semi-quantitatively measure urinary albumin and creatinine for kidney health assessment. It functions by using a smartphone application with computer vision algorithms to analyze color changes on an ACR Reagent Strip via reflectance photometry, referencing a proprietary Color-Board, to determine the albumin-creatinine ratio.

The Minuteful - kidney test is a prescription-only, in-vitro diagnostic system designed for home use by individuals at risk of kidney disease. It facilitates the semi-quantitative measurement of albumin and creatinine in urine, subsequently calculating and presenting the albumin-creatinine ratio (ACR) to aid in kidney health assessment. The system comprises a kit containing an ACR Reagent Strip, a proprietary Color-Board, a urine receptacle, and a blotting pad, alongside a smartphone application. This application guides users through the test procedure and employs computer vision and machine learning algorithms to analyze images of the reagent strip against the Color-Board, utilizing reflectance photometry for detection. An Image Validation Transfer System (IVTS) ensures compatibility across a wide range of smartphone devices. Analytical performance evaluations demonstrated high precision, with 100% exact matches in repeatability, reproducibility, and linearity testing for albumin, creatinine, and ACR. The device also passed stability tests under simulated aging and transportation conditions, and was evaluated for interference and limit of detection according to CLSI guidelines. Clinical performance was assessed in a method comparison study involving over 450 lay users, comparing results to the URiSCAN Optima Urine Analyzer. This study reported an exact agreement of 92.7% for ACR, 92.1% for albumin, and 88.2% for creatinine, with 100% agreement within ±1 color block for all analytes. Usability was high, with 100% of subjects successfully completing the test on their first attempt without issues.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What is the clinical impact of the 88.2% exact agreement for creatinine, especially in differentiating between ACR categories or for patients near diagnostic thresholds?; How does the Image Validation Transfer System (IVTS) technically ensure consistent image quality and analysis accuracy across the wide spectrum of smartphone camera specifications and ambient lighting conditions typically found in home environments?; Could you provide details on the specific substances and their concentrations tested for interference, and what were the acceptance criteria for determining no significant impact?; What are the defined 'at risk of kidney disease' criteria that clinicians should use to determine patient eligibility for a prescription of the Minuteful - kidney test?; Beyond the initial usability study, what long-term user support, re-education materials, or troubleshooting features are integrated into the Minuteful system to assist lay users who might encounter challenges or errors during home use over time?